A Xarelto lawsuit claims that after five-months of use, the drug caused an Ohio man to suffer from a life-threatening rectal bleed.

Plaintiff Johnny B. filed the Xarelto lawsuit against Janssen Research & Development and Bayer Pharmaceuticals. Janssen Research & Development is formally known as Johnson & Johnson Pharmaceuticals and Research.

According to the Xarelto lawsuit, Johnny began using Xarelto in January 2013 in order to reduce his risk of suffering from pulmonary embolisms. After taking the medication for approximately 5 months, Johnny stopped taking Xarelto when he began to allegedly experience life-threatening rectal bleeding.

The plaintiff claims that Xarelto manufacturers failed to warn the medical community and general public about serious risks associated with taking the blood thinner. The Xarelto lawsuit also alleges that the defendants concealed their knowledge of Xarelto side effects from the plaintiff and the general public.

According to the Xarelto allegations, Johnny experienced severe and permanent injuries along with ongoing pain and emotional distress. Johnny further asserts claims of negligence, strict products liability, breach of warranty, fraudulent misrepresentation, fraud and deceit.

Johnny is seeking compensatory damages for his injuries and pain and suffering, attorneys fees, reimbursement for the cost of the proceedings, and other compensation as the court sees fit.

What is Xarelto?

Xarelto is a popular new blood thinning medication on the market. It is primarily used to reduce the risk of stroke and systemic embolisms in patients with atrial fibrillation, and to reduce the risk of clotting in patients who have undergone knee or hip replacement surgery.

Xarelto was FDA approved for consumer use in 2011. It is one drug in a whole generation of new anticoagulant medications that transformed how patients live with clotting risks.

Prior to these medications entering the market, many patients were prescribed Warfarin, also known as Coumadin, to reduce clotting risks. Patients taking Warfarin are required to undergo a strict diet and must have regular blood monitoring to ensure they are taking the proper dosage.

Xarelto and many of the new drugs on the market do not share these requirements and are given to patients in set doses. Unfortunately when these new blood thinning medications entered the market they had no known antidote unlike Warfarin.

Patients who take Warfarin and suffer uncontrolled bleeding can be given a dose of vitamin K mixed with fresh or frozen plasma in order to reduce the anticoagulant effects of the medication.

FDA adverse event reports suggest that blood thinning medications are some of the most dangerous on the market. The adverse event reports suggest that many patients have suffered from uncontrolled bleeding and other serious side effects.

Xarelto Bleeding Lawsuits

Several Xarelto lawsuits have been filed in federal courts across the United States. Product liability attorneys are currently looking for new potential plaintiffs to bring Xarelto lawsuits.

A Xarelto lawyer can help weigh a potential plaintiffs facts and assist in determining whether or not a Xarelto lawsuit should be brought. Successful plaintiffs may receive signification compensation for their injuries.

The Xarelto Lawsuit is Case No. 2:15-cv-01149-EEF-MBN and MDL No. 2592 in the U.S. District Court in the Eastern District of Louisiana.